.Pharmacolibrary.Drugs.ATC.N.N05AH04 .Pharmacolibrary.Drugs.ATC.N.N05AH04| name: | Quetiapine |
| ATC code: | N05AH04 | route: | oral |
| n-compartments | 2 |
Quetiapine is an atypical antipsychotic medication approved for the treatment of schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder. It acts mainly by antagonism of serotonin (5-HT2A) and dopamine (D2) receptors. Quetiapine is widely prescribed and remains in routine clinical use today.
Pharmacokinetic parameters from healthy adult volunteers after single-dose oral administration.
Fukushi, R, et al., & Takada, A (2020). Population Pharmacokinetics Analysis of Quetiapine Extended-release Formulation in Japanese Patients with Bipolar Depression. Clinical therapeutics 42(6) 1067–1076.e2. DOI:10.1016/j.clinthera.2020.04.006 PUBMED:https://pubmed.ncbi.nlm.nih.gov/32518042
Lin, M, et al., & Zhao, Q (2024). The impact of CYP3A5*3 on oral quetiapine: A population pharmacokinetic model in Chinese bipolar disorder patients. Journal of affective disorders 351 309–313. DOI:10.1016/j.jad.2024.01.170 PUBMED:https://pubmed.ncbi.nlm.nih.gov/38262522
Li, Q, et al., & Si, TM (2014). Pharmacokinetics and tolerability of extended-release quetiapine fumarate in Han Chinese patients with schizophrenia. Clinical pharmacokinetics 53(5) 455–465. DOI:10.1007/s40262-013-0127-9 PUBMED:https://pubmed.ncbi.nlm.nih.gov/24385309